Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients

Pierre Walczak; Sylvain Choquet; Jacques Dantal; David Boutboul; Felipe Suarez; Marine Baron; Veronique Morel; Thomas Cluzeau; Mohamed Touati; Michelle Elias; Emmanuel Bachy; Emmanuelle Nicolas-Virelizier; Roch Houot; Geoffroy Venton; Caroline Jacquet; Marie-Pierre Moles-Moreau; Fabrice Jardin; Eric Durot; Noureddine Balegroune; Laure Ecotiere; Romain Guieze; Nassim Kamar; Loic Ysebaert; Lionel Couzi; Hugo Gonzalez; Louise Roulin; Kevin Ou; Sophie Caillard; Heiner Zimmermann; Ralf Ulrich Trappe; Damien Roos-Weil

doi:10.3324/haematol.2022.282297

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients

Haematologica. 2023 Oct 1;108(10):2814-2819. doi: 10.3324/haematol.2022.282297.

Authors

Pierre Walczak¹, Sylvain Choquet¹, Jacques Dantal², David Boutboul³, Felipe Suarez⁴, Marine Baron¹, Veronique Morel¹, Thomas Cluzeau⁵, Mohamed Touati⁶, Michelle Elias⁷, Emmanuel Bachy⁸, Emmanuelle Nicolas-Virelizier⁹, Roch Houot¹⁰, Geoffroy Venton¹¹, Caroline Jacquet¹², Marie-Pierre Moles-Moreau¹³, Fabrice Jardin¹⁴, Eric Durot¹⁵, Noureddine Balegroune¹, Laure Ecotiere¹⁶, Romain Guieze¹⁷, Nassim Kamar¹⁸, Loic Ysebaert¹⁹, Lionel Couzi²⁰, Hugo Gonzalez²¹, Louise Roulin²², Kevin Ou²³, Sophie Caillard²⁴, Heiner Zimmermann²⁵, Ralf Ulrich Trappe²⁶, Damien Roos-Weil²⁷

Affiliations

¹ Sorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.
² Institut de Transplantation Urologie Nephrologie (ITUN), Service de Nephrologie et Immunologie clinique, CHU Nantes, Nantes.
³ Service d'Immunologie Clinique, Hopital Saint-Louis, APHP, Paris.
⁴ Service d'Hematologie Clinique, Hopital Necker, APHP, Paris.
⁵ Service d'Hematologie Clinique, CHU de Nice, Nice.
⁶ Service d'Hematologie Clinique, CHU Limoges, Limoges.
⁷ Service de Nephrologie, Hopital Saint-Louis, APHP, Paris.
⁸ Service d'Hematologie Clinique, Hospices Civils de Lyon, Pierre-Benite.
⁹ Service d'Hematologie, Centre Leon Berard, Lyon.
¹⁰ Service d'hematologie, CHU Rennes, Universite de Rennes, INSERM U1236, Rennes.
¹¹ Service d'Hematologie et Therapie Cellulaire, Hopital universitaire de la Conception, Marseille.
¹² Service d'Hematologie, CHU de Nancy, Vandoeuvre les Nancy.
¹³ Service d'Hematologie, CHU d'Angers, Angers.
¹⁴ Service d'Hematologie, Centre Henri Becquerel, Rouen.
¹⁵ CHU Reims, Hematologie Clinique, F-51100 Reims.
¹⁶ Service de Nephrologie, Hemodialyse et Transplantation renale, Centre Hospitalier Universitaire de Poitiers, Poitiers.
¹⁷ Service d'Hematologie Clinique et Therapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand France.
¹⁸ Service de Nephrologie et Transplantation d'Organes, CHU Rangueil, Toulouse.
¹⁹ Service d'Hematologie, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse.
²⁰ Service de Nephrologie, transplantation, dialyse et aphereses, CHU Bordeaux.
²¹ Service d'Hematologie, Centre Hospitalier Rene-Dubos, Pontoise.
²² Service Unite Hemopathies Lymphoides, Groupe Hospitalo-universitaire Chenevier Mondor, APHP Creteil.
²³ Service de Nephrologie et Transplantation Renale, Hopital Foch, Suresnes.
²⁴ Service de Nephrologie et Transplantation Renale, CHU de Strasbourg, Strasbourg.
²⁵ Department of Internal Medicine-Oncology, Carl v. Ossietzky University of Oldenburg, Pius-Hospital, Oldenburg, Germany; Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Gropelinger Heerstr. 406-408, 28239, Bremen.
²⁶ Department of Haematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Gropelinger Heerstr. 406-408, 28239, Bremen, Germany; Department of Internal Medicine II: Haematology and Oncology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel.
²⁷ Sorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris. damien.roosweil@aphp.fr.

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Burkitt Lymphoma* / drug therapy
Burkitt Lymphoma* / genetics
Cyclophosphamide / therapeutic use
Humans
Retrospective Studies

Substances

Cyclophosphamide

Grants and funding

Funding: This study was supported by grants from INCA-DGOS-INSERM-12560 (SiRIC CURAMUS is financially supported by the French National Cancer Institute, the French Ministry of Solidarity and Health and INSERM with financial support from ITMO Cancer AVIESAN).